BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

There is little information on BNT162b2 vaccine-induced variant-specific immunogenicity, safety data and dynamics of breakthrough infections in pediatric populations. We addressed these questions using a prospective two dose BNT162b2 (10 mcg) vaccination cohort study of healthy children 5-11 years i...

Full description

Bibliographic Details
Main Authors: Yung, Chee Fu, Le Bert, Nina, Kam, Kai Qian, Saffari, Seyed Ehsan, Tan, Chee Wah, Mah, Yun Yan, Zhang, Jinyan, Yeoh, Aileen Ying-Yan, Zhu, Feng, Hariharaputran, Smrithi, Chong, Chia Yin, Bertoletti, Antonio, Wang, Linfa
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Journal Article
Language:English
Published: 2024
Subjects:
Medicine, Health and Life Sciences
COVID-19
Breakthrough infection
Online Access:https://hdl.handle.net/10356/173890

Internet

https://hdl.handle.net/10356/173890

Similar Items